Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study.

There was a significant improvement in anthropometric parameters and body composition, in overweight and obese women with PCOS after 12 weeks of treatment with empagliflozin compared to metformin, although no changes were seen in hormonal or metabolic parameters.